Galectin Therapeutics

Manufacturing · Georgia, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

4960 Peachtree Industrial Blvd Ste 240, ...

Phone Number

(678) 620-3186

Revenue

$37.4 Million

Stock Symbol

GALT

Industry

Manufacturing Pharmaceuticals

About Galectin Therapeutics

Galectin Therapeutics develops innovative therapies aimed at improving the lives of patients suffering from chronic liver diseases, particularly Metabolic Dysfunction-Associated Steatohepatitis (MASH) cirrhosis, and cancer. Their lead product, belapectin (GR-MD-02), is a galectin-3 inhibitor that targets various inflammatory, fibrotic, and malignant diseases. The company is focused on advancing clinical studies, including the NAVIGATE study for MASH cirrhosis, to provide new treatment options where none currently exist. Galectin Therapeutics is dedicated to addressing the urgent medical needs of patients facing life-threatening conditions related to liver health and cancer.Explore more
Galectin Therapeutics's Social MediaSIC Code 28,283NAICS Code 32,325Ticker NASDAQ: GALTShow more

Galectin Therapeutics Org Chart

PhoneEmail
Khurram Jamil, Chief Medical Officer at Galectin Therapeutics
United States flag for contact location.

Chief Medical Officer

PhoneEmail
JC
United States flag for contact location.

Chief Financial Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
AV
United States flag for contact location.

Vice President, Clinical Pharmacology and Pha...

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Galectin Therapeutics

Compare insights from companies similar to Galectin Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Galectin Therapeutics

$37.4M
1-10
Public
$50M
2000
Khurram Jamil, Chief Medical Officer at Galectin Therapeutics
Khurram JamilChief Medical Officer
<$5M
11-50
Private
$5.1M
2004
<$5M
1-10
Private
$6.6M
1999
AB
Alexander BaguisiDirector Pre-clincal Biology
<$5M
1-10
Private
$7.5M
2005
BB
Brian BatteyChief Operating Officer
<$5M
1-10
Private
$17.8M
2008
Illustration of an envelope

Galectin Therapeutics Tech Stack

A closer look at the technologies used by Galectin Therapeutics

Top Manufacturing Companies

Frequently Asked Questions Regarding Galectin Therapeutics

What is Galectin Therapeutics's stock symbol?
Galectin Therapeutics's stock symbol is GALT
What is Galectin Therapeutics's official website?
Galectin Therapeutics's official website is www.galectintherapeutics.com
What is Galectin Therapeutics's Revenue?
Galectin Therapeutics's revenue is $37.4 Million
What is Galectin Therapeutics's SIC code?
Galectin Therapeutics's SIC: 28,283
What is Galectin Therapeutics's NAICS code?
Galectin Therapeutics's NAICS: 32,325
How many employees does Galectin Therapeutics have?
Galectin Therapeutics has 1-10 employees
What industry does Galectin Therapeutics belong to?
Galectin Therapeutics is in the industry of: Manufacturing, Pharmaceuticals
What is Galectin Therapeutics competition?
Galectin Therapeutics top competitors include: Ischemix, Bioleap, Cellworks Group, AgeneBio
What technology does Galectin Therapeutics use?
Some of the popular technologies that Galectin Therapeutics uses are: WordPress.org, reCAPTCHA, PHP, Cloudflare Website Optimization
Who is the CFO of Galectin Therapeutics?
Galectin Therapeutics's CFO is Jack Callicutt
How do I contact Galectin Therapeutics?
Galectin Therapeutics contact info: Phone number: (678) 620-3186 Website: www.galectintherapeutics.com
What does Galectin Therapeutics do?

Galectin Therapeutics develops innovative therapies aimed at improving the lives of patients suffering from chronic liver diseases, particularly Metabolic Dysfunction-Associated Steatohepatitis (MASH) cirrhosis, and cancer. Their lead product, belapectin (GR-MD-02), is a galectin-3 inhibitor that targets various inflammatory, fibrotic, and malignan... t diseases. The company is focused on advancing clinical studies, including the NAVIGATE study for MASH cirrhosis, to provide new treatment options where none currently exist. Galectin Therapeutics is dedicated to addressing the urgent medical needs of patients facing life-threatening conditions related to liver health and cancer.Read More

What are Galectin Therapeutics social media links?
Galectin Therapeutics Linkedin page Galectin Therapeutics Twitter page Galectin Therapeutics Facebook page
Is Galectin Therapeutics a public company?
Yes, Galectin Therapeutics is a public company and is traded under the symbol GALT
See more information about Galectin Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.